JP2000511411A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511411A5
JP2000511411A5 JP1997539170A JP53917097A JP2000511411A5 JP 2000511411 A5 JP2000511411 A5 JP 2000511411A5 JP 1997539170 A JP1997539170 A JP 1997539170A JP 53917097 A JP53917097 A JP 53917097A JP 2000511411 A5 JP2000511411 A5 JP 2000511411A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997539170A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000511411A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/007198 external-priority patent/WO1997041151A2/en
Publication of JP2000511411A publication Critical patent/JP2000511411A/ja
Publication of JP2000511411A5 publication Critical patent/JP2000511411A5/ja
Pending legal-status Critical Current

Links

JP09539170A 1996-05-01 1997-05-01 抗―肺炎球菌ワクチン用のコリン結合タンパク質 Pending JP2000511411A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US64225096A 1996-05-01 1996-05-01
US1663296P 1996-05-01 1996-05-01
US08/642,250 1996-05-01
US60/016,632 1996-05-01
PCT/US1997/007198 WO1997041151A2 (en) 1996-05-01 1997-05-01 Choline binding proteins for anti-pneumococcal vaccines

Publications (2)

Publication Number Publication Date
JP2000511411A JP2000511411A (ja) 2000-09-05
JP2000511411A5 true JP2000511411A5 (enExample) 2005-01-13

Family

ID=26688869

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09539170A Pending JP2000511411A (ja) 1996-05-01 1997-05-01 抗―肺炎球菌ワクチン用のコリン結合タンパク質

Country Status (8)

Country Link
EP (1) EP0912608B1 (enExample)
JP (1) JP2000511411A (enExample)
AT (1) ATE323721T1 (enExample)
AU (1) AU732520B2 (enExample)
CA (1) CA2253252A1 (enExample)
DE (1) DE69735715T2 (enExample)
ES (1) ES2262177T3 (enExample)
WO (1) WO1997041151A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US6245335B1 (en) 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
WO1998021337A2 (en) * 1996-11-12 1998-05-22 Regents Of The University Of Minnesota C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
DE19708537A1 (de) * 1997-03-03 1998-09-10 Biotechnolog Forschung Gmbh Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
US6676943B1 (en) 1997-04-24 2004-01-13 Regents Of The University Of Minnesota Human complement C3-degrading protein from Streptococcus pneumoniae
CN1200731C (zh) * 1998-04-07 2005-05-11 免疫医疗公司 用作疫苗的肺炎球菌胆碱结合蛋白衍生物
US6858706B2 (en) 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
TR200003498T2 (tr) * 1998-04-07 2001-10-22 St. Jude Children's Research Hospital Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları
AU2004200125B2 (en) * 1998-04-07 2006-07-27 Med Immune, Inc. Derivatives of Pneumococcal Choline Binding Proteins for Vaccines
US20010016200A1 (en) 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
AU2027400A (en) * 1998-11-19 2000-06-05 St. Jude Children's Research Hospital Identification and characterization of novel pneumococcal choline binding proteins, cbpg and cbpd, and diagnostic and therapeutic uses thereof
US6495139B2 (en) 1998-11-19 2002-12-17 St. Jude Children's Research Hospital Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
CA2355364C (en) 1998-12-21 2014-03-18 Medimmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
ATE346608T1 (de) 1999-03-19 2006-12-15 Glaxosmithkline Biolog Sa Impstoff gegen streptococcus pneumoniae
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
DE20321889U1 (de) 2002-08-02 2012-03-12 Glaxosmithkline Biologicals S.A. Impfstoffzusammensetzung
KR101058978B1 (ko) 2002-11-01 2011-08-23 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
DE602004028262D1 (de) 2003-10-02 2010-09-02 Glaxosmithkline Biolog Sa B. pertussis antigene und ihre verwendung bei der vakzinierung
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
AR058592A1 (es) 2005-12-22 2008-02-13 Glaxosmithkline Biolog Sa Vacuna
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CN104436180B (zh) 2006-01-17 2021-08-31 阿恩·福斯格伦 新的表面外露流感嗜血菌蛋白质(蛋白质E;pE)
WO2009000824A2 (en) 2007-06-26 2008-12-31 Glaxosmithkline Biologicals S.A. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
PL2271360T3 (pl) 2008-04-16 2016-03-31 Glaxosmithkline Biologicals Sa Szczepionka
WO2010126146A1 (ja) * 2009-04-30 2010-11-04 Tanaka Noriaki 腎疾患重篤度を判定する方法又は装置若しくはその作動方法
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
CN102869378A (zh) 2010-03-10 2013-01-09 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
UY34073A (es) 2011-05-17 2013-01-03 Glaxosmithkline Biolog Sa Vacuna mejorada de streptococcus pneumoniae y métodos de preparación.
US11207396B2 (en) 2013-05-17 2021-12-28 The Board Of Regents Of The University Of Texas System Immunization to protect against adverse cardiac events relating to pneumococcal infection
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
KR20220123387A (ko) * 2019-11-18 2022-09-06 박사이트, 인코포레이티드 연쇄상구균 박테리아의 동물 유래 산물 비함유 배양

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024000A1 (en) * 1992-05-29 1993-12-09 Janet Yother Methods for obtaining and purifying cell-free pneumococcal surface proteins from s. pneumoniae and use thereof
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
CN1192241A (zh) * 1995-06-07 1998-09-02 生化疫苗公司 Hsp70家族的链球菌热休克蛋白

Similar Documents

Publication Publication Date Title
JP2000513396A5 (enExample)
JP2000514457A5 (enExample)
JP2000514445A5 (enExample)
JP2000514264A5 (enExample)
JP2000514475A5 (enExample)
JP2002514300A5 (enExample)
JP2000514731A5 (enExample)
JP2000507766A5 (enExample)
JP2000509299A5 (enExample)
JP2000513390A5 (enExample)
JP2001504009A5 (enExample)
JP2000507945A5 (enExample)
JP2001505550A5 (enExample)
JP2001504900A5 (enExample)
JP2000511510A5 (enExample)
JP2000509023A5 (enExample)
JP2000508006A5 (enExample)
JP2000516830A5 (enExample)
JP2000511355A5 (enExample)
JP2000512184A5 (enExample)
JP2001507225A5 (enExample)
JP2000514019A5 (enExample)
JP2000508995A5 (enExample)
JP2000510882A5 (enExample)
JP2000502570A5 (enExample)